CD274 and non-small cell lung carcinoma: Despite the mono-centric nature of our work and the related study samples, to our knowledge this represents the first reported work comparing the two regimens in the front-line setting of patients with non-squamous NSCLC and PD-L1<50%, with focus also on results with subsequent treatments.